Investor Relations Contacts

Sarah Cavanaugh
Senior Vice President
Corporate Affairs and Administration

Dec 2, 2020 4:20 PM EST	3rd Annual Evercore ISI HealthCONx Conference Listen to webcast

Sep 16, 2020 9:00 AM EDT	HC Wainwright & CO 22nd Annual Global Investment Virtual Conference Fireside Chat Listen to webcast

Sep 15, 2020 10:40 AM EDT	Cantor Virtual Global Healthcare Conference Fireside Chat Listen to webcast

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

Investor Relations Contacts

Events & Presentations

About us

Our Pipeline